Status:
COMPLETED
Evaluation of s100β, NSE and GFAP Levels in Renal Transplantation
Lead Sponsor:
Akdeniz University
Conditions:
Kidney Transplant; Complications
Neurologic Manifestations
Eligibility:
All Genders
18+ years
Brief Summary
Uremic encephalopathy is an organic brain disorder may be frequently seen in patients with acute or chronic renal failure. Certain neurological symptoms can be found under clinical glomerular filtrati...
Detailed Description
Encephalopathy, thiamine deficiency, uremia, hypertension, electrolyte imbalance after dialysis are clinical pictures with high incidences in case of renal failure. There are multifactor reasons in it...
Eligibility Criteria
Inclusion
- End-stage renal failure patients
- Healthy volunteer patients.
Exclusion
- Nonvolunteers
- Active infections
- Oncologic or hematologic diseases
- Cadaver graft recipients
- History with psychoactive medications
- History with a respiratory system or central nervous system disorders
- Severe heart failure
Key Trial Info
Start Date :
August 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 15 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04042272
Start Date
August 15 2019
End Date
January 15 2021
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akdeniz University Hospital
Antalya, Turkey (Türkiye), 07070